Market Research Blog

Increasing number of post-operative eye infections, emergence of new pathogens and poor eye hygiene practices are increasing the prevalence of eye infections worldwide. With the incidence unlikely to reduce anytime soon, Future Market Insights (FMI) in a study has reported the demand for ophthalmic eye drops to rise at above 5% CAGR between 2021 and 2031.

The National Ambulatory Medical Care Survey indicated that Americans made more than 4 million visits to ambulatory physicians for bacterial conjunctivitis in 2005. Approximately 70% of patients with acute conjunctivitis present to primary and urgent care providers, which accounts for 1% of all primary care office visits. Adenoviruses account for 65 to 90% of cases of viral conjunctivitis.

The soaring cases of eye infections have been driving ophthalmic eye drops sales. While the report presents positive outlook for growth, ongoing restrictions amid COVID-19 outbreak might hamper sales.

COVID-19 pandemic is expected to negatively impact the ophthalmic eye drops market. Significant reduction in physician office visits and subsequent decline in the number of prescriptions and OTC eye drop purchases are expected to hamper the market growth during the COVID-19 pandemic. Speedy vaccination programs against COVID are expected to enable market recovery in the coming 1-2 years.

Need More information about Report Methodology? Click here @

https://www.futuremarketinsights.com/reports/sample/rep-gb-13140

New eye drop product launches, branded as well as generic, are expected to be hampered in the short term due to disruptions in the supply chain, delayed pipeline research and development and shift in the priority of leading healthcare companies to COVID-19 vaccine and treatment developments.

According to the report, institutional sales of ophthalmic eye drops will rise considerably in the coming years. It will account for over half of ophthalmic eye drops sold through the forecast period.

Key Takeaways from Ophthalmic Eye Drops Market Study

• Ophthalmic eye drops market will expand consistently to surpass a valuation of US$ 15 Bn by 2021
• The U.S. holds over 92.1% share of the North American market, but Canada is projected to expand faster at around 4.0% CAGR
• Rising cases of eye infection will drive sales in the U.K., enabling it register 3.9% y-o-y growth in 2021
• Rising willingness to spend on advanced eye care will drive sales in Germany and France
• Expansion of the healthcare sector will emerge as chief growth driver in China and Japan. Both countries will exhibit high demand for dilation drops

“Increasing prevalence of eye infections, technological advancements, and high risk of infections from increasing use of contact lens are expected to boost the growth of the ophthalmic eye drops market.” says the FMI Analyst

Contact Sales for Further Assistance in Purchasing this Report@

https://www.futuremarketinsights.com/checkout/13140

Due to their increasingly active lifestyle and desire for better aesthetics, many people are shifting to contact lenses. However, many ocular infections are associated with the use of contact lenses. Each year in the United States, approximately 1 million eye infections occur related primarily to keratitis, a fungal infection of the cornea, and contact lens infections account for estimated direct costs of $175 million. In addition, 40.9 million U.S. adults wear contact lenses, and 99% of 4,269 contact-lens wearers were reported at least one contact lens – related hygiene behavior associated with an increased risk for eye infection or inflammation. Nearly a million eye infections requiring a trip to the doctor happen each year, many of them related to contact lens use.

Who is Winning?

The top players are focusing on increasing acquisitions at the regional level. Acquisitions empower the company with products and increase the company’s portfolio. The company acquires other players to possess well-established products and solutions that are expected to become a good revenue source for the acquirer. Acquisitions also enable the company to enter new emerging markets as well as enhance their presence in existing markets. Furthermore, key market players such as Novartis and Gerresheimer AG are focusing on the expansion of their market reach in different regions. For example-

• In November 2020, Gerresheimer Regensburg announced that it is expanding its production area in Germany. The company has planned the expansion of its production capacity in small batch production, as a result of increasing development projects for pharmaceutical and medical technology products.
• In November 2019, Sandoz announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited, strengthening its position in the world’s third largest generics market.

Some of the key market players covered by FMI include Novartis AG, Bausch & Lomb, Akorn, Inc., Biomedica, AdvaCare Pharma, C2 PHARMA, Kraeber GmbH, Iskon Remedies, HANSHIN GROUP, Berry Global Inc., Nolato AB, Bormioli Pharma, WG Pro-Manufacturing Inc., Gerresheimer AG, Adelphi Healthcare Packaging, Aptar Group Inc., and Amcor Plc.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

Sterilants sales will continue rising as focus on maintaining a clean and hygienic environment increases to prevent the spread of infections. Future Market Insights in a new study has predicted the sterilants market to reach US$ 2.31 Bn by 2021. Sterilants are chemical agents that destroy (or irreversibly inactivate) bacteria, fungi, and viruses, including their spores. They are also known as sporicides or sterilizers.

The sterilants market is expected to grow significantly in terms of revenue over the forecast period owing to the rising incidence of infectious disease transmission and surging demand for compatible sterilants. Among products available, the demand for ethylene oxide (EtO) is expected to remain considerably high. It is expected to account for over one-fourth sales in the market.

Need More information about Report Methodology? Click here @

https://www.futuremarketinsights.com/reports/sample/rep-gb-13126

Demand for sterilants is poised to surge especially amid the COVID-19 outbreak. Consecutive waves of the pandemic has put hospitals and healthcare clinics under pressure to efficiently manage a rising footfall of patients. While the healthcare sector is pulling up the sleeves to contain the soaring number of cases infected with the virus, focus on maintaining a clean and hygienic environment is rising as well.

Healthcare organizations are adopting various policies to respond to the pandemic, one of them being increasing investment in sanitization and sterilants to prevent the risk of infection. Consequently, despite supply chain disruptions witnessed amid the crisis, the demand for sterilants will continue rising.

Key Takeaways from Sterilants Market Study

• Global sterilants market is estimated to rise at a CAGR of 5.9% during the forecast period (2021-2031)
• Presence of a sophisticated healthcare infrastructure and willingness to spend on health and hygiene will support sales in the U.S., which will account for 88% of the North America market in 2021
• Despite ongoing restriction to contain pandemic, the U.K. market will continue rising. In 2021 it is expected to register 4.3% y-o-y growth
• Expansion of the healthcare sector will creative conducive environment for growth in India
• Rising disposable income and favorable insurance policies will support the expansion of sterilants market in China

 “Competition in the sterilants market is rising. Consequently the existing market players are likelier to focus on expansion strategies besides product launches. Some of them are entering into strategic collaborations will other companies,” says the FMI Analyst.

Contact Sales for Further Assistance in Purchasing this Report@

https://www.futuremarketinsights.com/checkout/13126

Development of Effective and Compatible Sterilants to Meet the End Users’ Demand is A Key Strategy for Sterilants Market Players

The leading manufacturers are focusing on research and development to develop effective and compatible sterilants that can meet the end users’ demand. The current pandemic outbreak and the growing global demand for multifunctional sterilizing products have led the manufacturers to increase their research efforts and expand their product portfolio through innovative product launches. For instance, in 2020, in response to the pandemic situation of the coronavirus outbreak, Lanxess launched a high-level disinfectant named Rely+On Virkon.

Key Participant Insights

Some of the companies covered by FMI include 3M Company, Steris Plc., Cantel Medical Corporation, Evonik Industries AG, Arkema S.A., Thor Group, Metrex Research, LLC, Ecolab Inc., Solvay SA, LANXESS, Contec, Inc., OZU Corporation, Cetylite, Inc., Veltek Associates, Inc., Whiteley Corporation, Gul Biyoloji Laboratuvari, and others. These players are consolidating their positions through mergers, acquisitions and new product launches.  Besides this they are adopting various strategies to consolidate their market share.

For instance, in 2021, Steris Plc acquired Cantel, a global provider of infection prevention products and services primarily for endoscopy and dental customers, by entering into a definitive agreement through a U.S. subsidiary.

Want More Insights?

Future Market Insights (FMI) brings a comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global sterilants market is segmented in detail to cover every aspect of the market and present a complete market intelligence report to the reader. The study provides compelling insights on the sterilants market on basis of product type such as ethylene oxide (EtO), glutaraldehyde, hydrogen peroxide gas plasma (HPGP), vaporized hydrogen peroxide, immersion and vapor phase peracetic acid and others. Based on form, sterilants are segmented into liquids and sprays. Based on end-users, the market is segmented into hospitals, clinics, ambulatory surgical centers, diagnostic laboratories, reference laboratories, rehabilitation centers, long-term care centers, critical care centers, pharmaceutical & biotechnology companies, academics and research institutes and homecare settings.

Increase In awareness regarding advanced skincare products and rising prevalence of chronic diseases are expected to drive skincare market. According to a study by Future Market Insights (FMI), the global skincare market is forecast to reach a valuation of US$ 8,823.4 Mn in 2021.

Skincare products such as skin cleansers, hand sanitizer, skin conditioners, and surgical scrubs are increasingly used to maintain skin hygiene and to prevent the spread of infections. The rising prevalence of chronic diseases and increase in demand for hand sanitizers amid COVID-19 pandemic is expected to boost the growth of the skincare market.

Moreover, increasing incidence of hospital-acquired diseases such as surgical site infection (SSI) is creating opportunities for growth. Sales will surge further as a result of the increasing awareness about advanced skincare products. Social media & innovative online campaigns aimed at creating awareness are therefore reshaping the skincare market.

Need More information about Report Methodology? Click here @

https://www.futuremarketinsights.com/reports/sample/rep-gb-13122

Increasing market consolidation activities, adoption of strategic agreements among the leading manufacturers and increasing research activities aimed at launching effective products are some of the factors enabling growth. Some of the leading players are aiming to strengthen their product portfolio by launching a various online campaign. For instance, in 2021, Galderma Laboratories, L.P.-Cetaphil launched an innovative digital campaign to connect with millions of consumers experiencing skin sensitivity.with the market expected to exhibit a CAGR of 8.1% during the forecast period (2021-2031)

Key Takeaways from Skincare Market Study

• Skincare market is expected to rise at 8.1% CAGR between 2021 and 2031
• High willingness among consumers to spend on personal health and hygiene will drive growth in the U.S., which will account for over 85% of sales in North America by 2031
• The U.K. will remain a key market for skincare products within Europe. Rising demand from various hospitals, healthcare, and critical care centers will continue supporting growth
• Expansion of the healthcare sector will push growth in Germany, which will account for maximum skincare products sales within Europe’s healthcare sector
• Strong growth is likely in China, as consumers increasingly focus on hygiene and sanitization to prevent the risk of infection

“Rising Prevalence of Surgical-site infections and infective diseases and growing demand for hand sanitizers are driving the growth of global skincare market. Key players trying to partner with R&D Companies, patent licensees & holders, reputable manufacturers, prestigious universities, government agencies worldwide to develop and commercializing novel products based on pioneered and patented technologies,” said a lead FMI analyst.

Contact Sales for Further Assistance in Purchasing this Report@

https://www.futuremarketinsights.com/checkout/13122

Who is Winning?

The leading manufacturers are focusing on research and development to develop effective and compatible skincare products that can meet the end-use demand. The current pandemic outbreaks and the growing demand for hand sanitizing product have led manufacturers to ramp up their research efforts to expand their product portfolio.

Besides this, several key players are focusing on market consolidation activities such as a merger, acquisition, supply distribution partnerships, and launching new products. This is leading to high competitiveness in the market. Key manufacturers are also keen to expand the market footprint.

For instance, in 2020, GOJO has expanded its product portfolio to increases sales of PURELL sanitizer, wipes, soap and surface spray by establishing a new manufacturing facility in Maple Heights and Navarre, Ohio.

Some of the market players covered by FMI include are 3M Company, Cardinal Health, Inc., Ecolab, Whiteley Corporation, Reckitt Benckiser Group PLC, Carrollclean, Johnson & Johnson Consumer Inc., Galderma Laboratories, L.P., PDI, Inc., Betco Corporation, Pal International, PSK Pharma Pvt. Ltd., Metrex Research, LLC., Gojo Industries, Inc., Unilever, Steris Plc, Procter & Gamble and among others consolidating their positions through mergers, acquisitions and new product launches.

Want more insights?

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global skincare market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the skincare market on basis of product such as Skin Cleansers, Hand Sanitizers, Surgical Scrubs, Skin Conditioner and Other. Based on form the skincare market is segmented as Liquid, Gel & Lotions, Wipes and Spray & Foams. Based on end-users such as Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Reference Laboratories, Rehabilitation Centers, Long Term Care Centers, Critical Care Centers, Pharmaceutical & Biotechnology Companies, Academics and Research Institutes and Homecare Settings across seven major regions.

Global vision screener sales are likely to near US$ 500 Mn by the end of 2019. According to a new research intelligence study presented by Future Market Insights (FMI), the market for vision screeners will continue to witness an average 5.5% Y-o-Y growth in the revenues in 2019 and ahead. As reported by the study, more than a third of overall sales of vision screeners is targeted to a variety of vision screening tests, followed by color vision tests.

While portable or handheld vision screening devices have been sought after over the years, it is more likely that the vision screening software will experience rapid gains in coming years, as a result of brisk technological penetration. Moreover, as key manufacturers are investing considerable efforts in technological innovations of vision screeners, table-top variants are also likely to see healthy sales growth in the near future. Currently, more than 50% of the total sales are accounted by portable or handheld devices that are used during vision screening procedures, as per the report.

The rising prevalence of vision problems, advancements in technology, increasing healthcare spending, and the growing prevalence of diabetes constitute some of the key factors responsible for driving the global vision screeners market revenues. In addition to some of the most commonplace vision disorders, newly establishing problems such as digital eye strain (more popularly, computer vision syndrome) are strongly necessitating the demand for efficient vision screening tests, particularly among the younger population. This, according to FMI’s analysis, will drive sales of vision screeners in the forthcoming years.

Need More information about Report Methodology? Click here @

https://www.futuremarketinsights.com/reports/sample/rep-gb-5032

Inadequate Effectiveness of Vision Screening Tests Prevails in Developing Asian Markets

Accounting for a collective value share of over 60%, North America and Europe will continue to lead the pack in global vision screeners market. In addition to early adoption of advanced technologies and high awareness about vision problems and the significance of vision screening, the growth of market in these regions has been prominently attributed to the rapid consolidation of healthcare facilities within these regions.

On the other hand, dearth of skilled and trained professionals in the field of vision screening will remain the prime factor restraining vision screeners adoption across developing Asian countries. Relatively lesser competency to professionally and accurately assess vision screening results continues to pose significant barriers in the growth path of market within Asia Pacific (APAC).

According to the report, a sizeable number of vision screening tests cannot be performed on children who have reading problems such as hyperopia or astigmatism. As a result, the ineffectiveness of vision screeners continues to negatively influence the number of parents opting for pediatric vision screening tests, which is further a significant factor deterring the revenues of vision screeners market in APAC.

Pediatric Vision Screening Emerging as a Prime Focus Area for Innovations

Some of the key players competing in the global vision screeners market landscape include Hill-Rom Holdings, Inc. (Welch Allyn), Essilor International S.A. (Stereo Optical Company Inc.), Adaptica S.r.l., OCULUS Surgical, Inc., Plusoptix Inc., Honeywell International Inc., FIM Medical SAS, SHANGHAI TOP VIEW INDUSTRIAL CO., LTD., Thomson Screening Solutions Ltd., and Keystone View. While a majority of these companies are concentrating in technological upgrades of the current offerings, augmented investments targeting FDA approvals will be an important strategy.

Contact Sales for Further Assistance in Purchasing this Report@

https://www.futuremarketinsights.com/checkout/5032

Moreover, multiple longstanding challenges prevailing in children’s vision screening are highly likely to push the scope for innovations, which would help overcome the challenges and extend the efficiency of vision screening – specifically for children. The FMI study reveals how the companies that are manufacturing, supplying, and distributing vision screeners are strategizing on the growing traction in the pediatric patients segment.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

Animal Microchip Implant Market Overview

An animal microchip implant is an innovative technology used for tracking pet animals and other healthcare issues in animals. Microchips implanted in pet animals are used to track the movement of pets to prevent the loss of pet animals. A microchip implant is a small device that can be implanted under the pet’s skin and works as an identification for that particular pet with all the pet’s information. Microchips implanted in pets have all the basic details, such as owner’s name and address and vital details with past and present medical history. Microchips have a 15-digit number, which can be scanned under a database for all the major and minor details of a pet. They provide real-time data of a pet’s locations. Two types of microchip implants are available in the market. The first, surgery-injectable implants, need be placed by veterinary surgeons and the second are available as self-implanted injectable microchips. Many tags are also available, which can be placed near the neck or other tag areas on pets. Apart from pet animals, farm animals are also implanted with microchips to monitor the activities of farm animals and track details such as vitals, health-related information and other details pertaining to the farm or the owner.

Get Free 20% customization on Pre-Booking:

https://www.futuremarketinsights.com/checkout/6881

Animal Microchip Implant Market: Drivers and Restraints

The animal microchip implant market is pegged to witness significant growth over the forecast period as pet adoptions are increasing and pet owners are becoming more aware regarding the technology. Players such as Wuxi Fofia Technology Co., Ltd, and Autag Technology Europe BV are creating a database of all animals, including pets and farm animals. Technological advancement is a major contributor to the increase in the number of animal microchip implants across the globe. On the other hand, lack of focus in veterinary health expenditure, lack of awareness regarding implant use and process to implant inside or outside the animals and others factors are expected to hinder the growth of the market.

Animal Microchip Implant Market: Overview

The animal microchip implant market is primarily driven by increasing pet adoption and awareness about animals. Animals are well managed with the help of microchip implants, which provide all the necessary details needed by animal owners. This has resulted in an increase in the number of microchip implants in animals. Other factors leading to the growth of the animal microchip implant market include the increasing number of animal management systems in farms and individual animal owners.

Animal Microchip Implant Market: Region-wise Outlook

Geographically, the animal microchip implant market can be segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa. North America is the major market for animal microchip implants as animal health expenditures in the region are relatively high as compared to other regions. Additionally, pet adoption is increasing among the population and individuals are aware of veterinary health managements with animal monitoring. Europe and Asia Pacific are growing markets for animal microchip implants as microchips help monitor and manage animals and the introduction of new veterinary technology is increasing in these regions. The MEA region is also focusing on animal management and protection.

For more insights, You can request for TOC at @ 

https://www.futuremarketinsights.com/toc/rep-gb-6881

Animal Microchip Implant Market: Key Players

Some of the players identified in the animal microchip implant market include Zee Tags Ltd, Autag Technology Europe BV, Wuxi Fofia Technology Co., Ltd, I.D.ology, Microchip Identification Systems, Inc., Pet-ID Microchips Ltd, Shenzhen ZDCARD Tech Co., LTD, Quanzhou Hecere Electronic Limited, Ningbo Luke Medical Devices Ltd,  and other Radiofrequency identification (RFID) animal microchip manufacturers.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil and Rest of Latin America)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
• Eastern Europe (Poland, Russia and Rest of Eastern Europe)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Animal Microchip Implant Market: Segmentation

The animal microchip implant market can be segmented on the basis of the following parameters:

Product type:

• Animal ID Microchip
• Reusable Pet Tracking Microchip
• Transponder Microchips
• Others

Mode:

• Self-injectable
• Surgery-injectable

Distribution channel:

• Veterinary Hospitals
• Veterinary Clinics
• Veterinary Pharmaceutical Store
• Online Store

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry

Cellular Pathology Market: Dynamics

The Cellular pathology market is expected to mark a significant growth in the coming few years due to high probability of increase in number of cancer patient. Histopathology and cytopathology have been the main tools utilized in the diagnosis of cancer. The increased demand for pathology services is one of the major driving factor. Addition to this, government support and technological advancement are also boosting the growth of this market. However, there are some restraining factors which are restricting the growth of this market. Such as to comply with guidelines for cancer case reporting and with the various recommendations of specimen handling and additional testing, the need to improve turnaround time as a critical element in clinical management; and the need to comply with the statutory requirements of the various laboratory accreditation and quality assurance regulatory bodies.

Cellular Pathology Market: Overview

The global market for Cellular pathology market is expected to witness high growth over the forecast period. The high demand of Histopathology diagnosis due to increasing number of cancer patients. Histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, in clinical medicine. The specimen has been processed and histological sections have been placed onto glass slides. This diagnosis provides the exact results of presence of disease in body. This is very necessary process to avoid error arising in the diagnostic phase, among the clinician and the pathologists.

In developed countries, scientists and health researchers are addressing the threat of cancer to humans by attempting to provide appropriate service to end users.

Get Free 20% customization on Pre-Booking:

https://www.futuremarketinsights.com/checkout/6869

Cellular Pathology Market: Key Players

The market for cellular pathology is consolidated with a presence of few strong players. CellPath Ltd is the major player operating in cellular pathology market. CellNass by CellPath Ltd., is the most trustable and adopted service in cellular pathology. The other prominent players identified in global cellular pathology market include Gilson, Inc., MilliporeSigma, Source BioScience are other major players operating in this market.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

For more insights, You can request for TOC at @ 

https://www.futuremarketinsights.com/toc/rep-gb-6869

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
• Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (India, Australia & New Zealand)
• Japan
• China
• The Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Cellular Pathology Market: Segmentation

Tentatively, global Cellular pathology market has been segmented on the basis of product, services and geography

Based on product type, global Cellular pathology market is segmented as below

• Equipment
• Block Trimmers
• Coldplates
• Grossing / Cut Up
• Heating Forceps & Tampers
• Macro Digital Imaging System
• Section Dryers & Ovens
• Sledge Microtome
• Slide Drying Hotplates
• Thermometers & Probes
• Wax Dispensers
• Consumables

Based on services, global Cellular pathology market is segmented as below

• Histopathology
• Dermatopathology
• Neuropathology
• Non-gynaecological cytology
• Immunohistochemistry, FISH testing and electron microscopy
• Frozen sections

Based on end user, global Cellular pathology market is segmented as below

• Hospitals
• Pathology Laboratories
• Clinical Research institutes
• Academic Institutes

Report Highlights:

• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.